Study to detect liver cancer early in people with cirrhosis
Part of Cancer, Digestive system clinical trials.
This study follows people with cirrhosis to see how best to detect liver cancer early. If you qualify, you may receive regular monitoring that could help find liver cancer sooner, when treatment is more likely to work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old (any gender).
- You are able and willing to sign informed consent to join the study.
- You have cirrhosis that has been diagnosed or can be confirmed by past testing.
- Your cirrhosis is linked to one of these causes: hepatitis B, hepatitis C, alcohol-related liver disease, fatty liver disease, or hemochromatosis (iron overload).
- You do NOT have a history of liver cancer (hepatocellular carcinoma).
- Your liver disease is not the most severe type (Child-Pugh C), and your care team thinks you are suitable for liver cancer surveillance.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well doctors can detect small, early liver cancer and then follow how it changes over time. It may help your care team choose the best next steps based on earlier, clearer detection.
This study tests whether offering an ultrasound and a blood test (alpha-fetoprotein) every 6 months can help find liver cancer early in people with cirrhosis (scarred liver) caused by conditions other than hepatitis B or C. The goal is to reduce deaths from liver cancer in this group.
This study tests a new way to screen for liver cancer in people with chronic liver disease, especially those with cirrhosis or significant liver scarring. It uses blood tests and imaging to catch cancer early.
This trial tests a new blood test to help detect liver cancer (HCC) or confirm it’s not present in people with cirrhosis who are being monitored. It may help improve how doctors screen for liver cancer and decide who needs further imaging or treatment.
This study is exploring a new way to predict how liver cirrhosis will progress. It may help doctors better understand and manage the condition.
This study compares ultrasound scans versus MRI scans to see which one better helps prevent deaths from liver cancer in people with cirrhosis. You may be assigned to one of the two imaging tests and follow-up visits to track whether liver cancer develops or is caught early.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.